Wuxi Biortus Biosciences is an innovation-driven contract research organization committed to high-quality R&D services in drug discovery.
Wuxi Biortus Biosciences is an innovation-driven contract research organization (CRO) committed to high-quality R&D services in support of drug discovery.To help our clients achieve their drug discovery goals, we have established five world-class research platforms. These are Recombinant Protein Production, Structural Biology (X-ray Crystallography and Cryo-EM), In Vitro Assays and Screening, Medicinal Chemistry, and Process Development. Through the years, our R&D team has developed a number of practical and innovative techniques of which some have already been granted patent.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 5, 2021 | Series B | ¥200M | 1 | Bayland Capital | — | Detail |
Nov 13, 2020 | Series A | $15M | 1 | Bayland Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Bayland Capital | Yes | Series B |